US Patent Issued to Regeneron Pharmaceuticals on March 24 for "Genetically modified T cell receptor mice" (New York, California Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,105, issued on March 24, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Genetically modified T cell receptor mice" was invented by Lynn Macdonald (Harrison, N.Y.), Andrew J. Murphy (Croton-on-Hudson, N.Y.), John McWhirter (Hastings-on-Hudson, N.Y.), Naxin Tu (Pleasantville, N.Y.), Vera Voronina (Sleepy Hollow, N.Y.), Cagan Gurer (Chappaqua, N.Y.), Karolina Meagher (Yorktown Heights, N.Y.) and Sean Stevens (Del Mar, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a genetically modified non-human animal that comprises in its genome unrearranged T cell receptor variable gene loci, as well as embryos, ce...